John Smither
Director/Board Member presso FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
John William Smither's current jobs include being a Director at Genelux Corp., a Director at eFFECTOR Therapeutics Operations, Inc., and an Independent Non-Executive Director at NewAmsterdam Pharma Co. NV.
He is also a Member of The American Institute of Certified Public Accountants, Financial Executives International, and the California Society of Certified Public Accountants.
His former jobs include being an Independent Director at Achaogen, Inc. from 2013 to 2020, an Independent Director at Principia Biopharma, Inc. in 2019, a Director at Dompe Biotec SpA, an Independent Director at Applied Molecular Transport, Inc. from 2022 to 2023, an Independent Director at eFFECTOR Therapeutics, Inc. from 2021 to 2023, the Vice President-Finance & Administration at Amgen, Inc. from 2001 to 2004, the Chief Financial Officer at Kythera Biopharmaceuticals LLC from 2007 to 2015, an Audit Partner at Ernst & Young LLP (Missouri), the Chief Financial Officer at Amgen Europe BV from 2001 to 2004, the Chief Financial Officer at Kite Pharma, Inc. from 2017 to 2018, the Chief Financial Officer at Unity Biotechnology, Inc. from 2016 to 2017, the Chief Financial Officer at Sienna Biopharmaceuticals, Inc. from 2016 to 2017, the Chief Financial Officer at Sienna Biopharmaceuticals, Inc. from 2018 to 2019, the Chief Financial Officer at Arcutis Biotherapeutics, Inc. from 2019 to 2021, and the Chief Financial Officer at Arcutis Biotherapeutics, Inc. from 2023 to 2024.
He obtained his undergraduate degree from California State University-Los Angeles.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 13/02/2024 | 152 757 ( 0.14% ) | 2 M $ | 31/03/2024 | |
GENELUX CORP.
0.03% | 13/09/2023 | 6 920 ( 0.03% ) | 44 496 $ | 31/03/2024 |
| 22/06/2023 | 966 ( 0.03% ) | 13 901 $ | 31/03/2024 | |
| 29/12/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di John Smither
| Società | Posizione | Inizio |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Director/Board Member | 06/02/2023 |
| GENELUX CORPORATION | Director/Board Member | 11/09/2023 |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Director/Board Member | 23/03/2018 |
Financial Executives International
 Financial Executives International Miscellaneous Commercial ServicesCommercial Services Financial Executives International enhances member professional development through peer networking, career planning services, conferences, publications and special reports, and research. Its members include Chief Financial Officers, Vice Presidents of Finance, Treasurers, and Controllers. The company was founded in December 1931 and is headquartered in Morristown, NJ. | Corporate Officer/Principal | - |
| California Society of Certified Public Accountants | Corporate Officer/Principal | - |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Corporate Officer/Principal | - |
Precedenti posizioni note di John Smither
| Società | Posizione | Fine |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 10/04/2024 |
| APPLIED MOLECULAR TRANSPORT INC. | Director/Board Member | 27/12/2023 |
| EFFECTOR THERAPEUTICS, INC. | Director/Board Member | 11/09/2023 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di John Smither
| California State University-Los Angeles | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 8 |
|---|---|
| AMGEN INC. | Health Technology |
| GENELUX CORPORATION | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
| APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| EFFECTOR THERAPEUTICS, INC. | Health Technology |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Health Technology |
| Aziende private | 11 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO. | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Commercial Services |
Financial Executives International
Financial Executives International Miscellaneous Commercial ServicesCommercial Services Financial Executives International enhances member professional development through peer networking, career planning services, conferences, publications and special reports, and research. Its members include Chief Financial Officers, Vice Presidents of Finance, Treasurers, and Controllers. The company was founded in December 1931 and is headquartered in Morristown, NJ. | Commercial Services |
| California Society of Certified Public Accountants | |
Dompe Biotec SpA
 Dompe Biotec SpA Pharmaceuticals: MajorHealth Technology Dompe Biotec SpA (Dompé Biotec SpA) provides biotechnological drugs. Its products are used for the treatment of haematology, infectious diseases, nephrology, oncology, transfusion units and neuro-oncology. The company was founded in 1988 and is headquartered in Milan, Italy | Health Technology |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The private company is based in Breda, Netherlands. | Distribution Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
eFFECTOR Therapeutics Operations, Inc.
eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Commercial Services |
- Borsa valori
- Insiders
- John Smither
